August 19, 2025
Mike Reddy for STAT

STAT+ | Health care CEOs harvest billions even as industry lags broader stock market

Annual executive compensation review of prominent health care companies found 275 CEOs earning $3.6 billion in 2024.

By Bob Herman and J. Emory Parker


STAT+ | OpenAI can’t have it both ways on GPT-5 and health

Why OpenAI may run into trouble with the FDA for promoting GPT-5's health advice with little supporting evidence

By Brittany Trang


STAT+ | Why direct-to-consumer sales are unlikely to significantly lower drug costs

Some experts say the move is unlikely to significantly help consumers, but see no harm in it. Others worry it could let the pharma industry off the hook.

By Elaine Chen



John Moore/Getty Images

STAT+ | Draft of major MAHA report calls for more education, less regulation — and offers few policies

A draft of a major Make America Healthy Again report has familiar points on issues like vaccines and food, suggests only studies on agricultural chemicals.

By Isabella Cueto, Sarah Todd, Elizabeth Cooney, O. Rose Broderick, and Anil Oza


More around STAT

In case you missed it

  • From April 2024: Cancer is a killer. So is the fear of it, STAT
  • A New Reality for Terminal Cancer: Longer Lives, With Chronic Uncertainty, WSJ
  • “Canary in the Coal Mine?” Cancer Researchers Turn to Crowdfunding, Oncology News Central
  • As mRNA falls out of favor for HHS, are cancer vaccines next?, STAT

Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.